BrosMed Announces CE Mark and Launch for Artimes™ Balloon Dilatation Catheter

October 19, 2013– BrosMed announced CE Mark and launch of its Artimes™ Balloon Dilatation Catheter, which is now approved in the EU for the  of improving myocardial blood flow in the localized stenotic lesion of the coronary arteries.

“We are so pleased to receive the CE Mark & launch the product to the EU market and we are expanding ourselves to other territories as well, the Artimes™ balloon catheter is new product which was designed by 10⁺ year experienced R&D team in the industry and now CE approval. We hope it will help physicians and benefit the patients” said Benny Lee, Chairman of the company.